Dexcom Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 GuidanceBusiness Wire • 10/30/25
Pomerantz Law Firm Announces the Filing of a Class Action Against DexCom, Inc. and Certain Officers – DXCMGlobeNewsWire • 10/30/25
DEXCOM ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against DexCom, Inc. and Encourages Investors to Contact the FirmGlobeNewsWire • 10/29/25
Insights Into DexCom (DXCM) Q3: Wall Street Projections for Key MetricsZacks Investment Research • 10/29/25
DCXM ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of DexCom, Inc. InvestorsBusiness Wire • 10/28/25
Rosen Law Firm Urges DexCom, Inc. (NASDAQ: DXCM) Stockholders with Large Losses to Contact the Firm for Information About Their RightsBusiness Wire • 10/28/25
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed DexCom, Inc. (DXCM)GlobeNewsWire • 10/28/25
Can Dexcom Deliver Strong Q3 Earnings on Stelo Gains and G7 Adoption?Zacks Investment Research • 10/28/25
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of DexCom, Inc. (DXCM) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the FirmGlobeNewsWire • 10/28/25
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DexCom, Inc. - DXCMPRNewsWire • 10/23/25
DexCom (DXCM) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research • 10/23/25
Dexcom Schedules Third Quarter 2025 Earnings Release and Conference Call for October 30, 2025 at 4:30 p.m. Eastern Time.Business Wire • 10/02/25
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DexCom, Inc. - DXCMGlobeNewsWire • 09/24/25
Dexcom Spotlights Upcoming Feature Launches, Improved Health Outcomes and Cost-Effectiveness With Dexcom Glucose Biosensing at EASD 2025Business Wire • 09/15/25
DexCom, Inc. (DXCM) Presents At Baird Global Healthcare Conference 2025 TranscriptSeeking Alpha • 09/10/25